1. Carcinogenic potential | European Medicines Agencyhttps://www.ema.europa.eu/en/carcinogenic‐potential(accessed 29 September 2020).
2. ICH(2014).ICH Guideline M7 – assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk.Guideline. https://doi.org/http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Multidisciplinary/M7/M7_R1_Addendum_Step_4_31Mar2017.pdf(accessed September 2020).
3. Is Avoidance of Genotoxic Intermediates/Impurities Tenable for Complex, Multistep Syntheses?
4. A Tool for the Semiquantitative Assessment of Potentially Genotoxic Impurity (PGI) Carryover into API Using Physicochemical Parameters and Process Conditions
5. Risk Assessment of Genotoxic Impurities in New Chemical Entities: Strategies To Demonstrate Control